Substituted benzo[i]phenanthridines as mammalian topoisomerase-targeting agents

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 8, 2003, Pages 1809-1820

  Makhey, Darshan ^a   Li, Dajie ^a   Zhao, Baoping ^a   Sim, Sai Peng ^b   Li, Tsai Kun ^b   Liu, Angela ^b   Liu, Leroy F ^b,c   LaVoie, Edmond J ^a,c  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 METHYLENEDIOXY 8,9 DIMETHOXY 5 METHYLBENZO[I]PHENANTHRIDINE; 2,3 METHYLENEDIOXY 8,9 DIMETHOXYBENZO[I]PHENANTHRIDINE; 2,3 METHYLENEDIOXY 8,9 METHYLENEDIOXYBENZO[I]PHENANTHRIDINE; 2,3,8,9 TETRAMETHOXYBENZO[I]PHENANTHRIDINE; 2,8,9 TRIMETHOXYBENZO[I]PHENANTHRIDINE; 3,8,9 TRIMETHOXYBENZO[I]PHENANTHRIDINE; 5 METHYL 2,3,8,9 TETRAMETHOXYBENZO[I]PHENANTHRIDINE; 8,9 DIMETHOXY 5 METHYL 2,3 METHYLENEDIOXYBENZO[I]PHENANTHRIDINE; DNA; DNA TOPOISOMERASE; NITIDINE; PHENANTHRIDINE DERIVATIVE; PROTOBERBERINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DNA CLEAVAGE; DNA DRUG COMPLEX; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; HUMAN CELL; LYMPHOBLASTOMA; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION;

MAMMALIA;

EID: 0037378169     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00053-1     Document Type: Article

References (51)

1. Wang J.C. Annu. Rev. Biochem. 54:1985;665.
2. Liu L. Annu. Rev. Biochem. 58:1989;351.
3. Chen A.Y., Liu L.F. Annu. Rev. Pharmacol. Toxicol. 34:1994;191.
4. Li T.-K., Liu L.F. Annu. Rev. Pharmacol. Toxicol. 41:2001;53.
5. Liu L.F., Wang J.C. Proc. Natl. Acad. Sci. U.S.A. 84:1987;7024.
6. Tsao Y.-P., Wu H-Y., Liu L.F. Cell. 56:1989;111.
7. Sun Q., Gatto B., Yu C., Liu A., Liu L.F., LaVoie E.J. Bioorg. Med. Chem. Lett. 4:1994;2871.
8. Chen A.Y., Yu C., Bodley A.L., Peng L.F., Liu L.F. Cancer Res. 53:1993;1332.
9. Sun Q., Gatto B., Yu C., Liu A., Liu L.F., LaVoie E.J. J. Med. Chem. 38:1995;3638.
10. Kim J.S., Gatto B., Yu C., Liu A., Liu L.F., LaVoie E.J. J. Med. Chem. 39:1996;992.
11. Makhey D., Gatto B., Yu C., Liu A., Liu L.F., LaVoie E.J. Med. Chem. Res. 5:1995;1.
12. Stermitz F.R., Gillespie J.P., Amoros L.G., Romero R., Stermitz T.A., Larson K.A., Earl S., Ogg J.E. J. Med. Chem. 18:1975;708.
13. Makhey D., Gatto B., Yu C., Liu A., Liu L.F., LaVoie E.J. Bioorg. Med. Chem. 4:1996;781.
14. Cushman M., Mohan P. J. Med. Chem. 28:1985;544.
15. Cushman M., Mohan P., Smith E.C. J. Med. Chem. 28:1984;1031.
16. Yamashita Y., Fujii N., Murakaya C., Ashizawa T., Okabe M., Nakano H. Biochemistry. 31:1992;12069.
17. Fujii N., Yamashita Y., Saitoh Y., Nakano H. J. Biol. Chem. 268:1993;13160.
18. Yamashita Y.; Kawada, S-Z.; Fujii, N.; Nakano, H. Biochemistry. 30:1991;5838.
19. Cushman M., Jayaraman M., Vroman J.A., Fukunaga A.K., Fox B., Kolhagen G., Strumberg D., Pommier Y. J. Med. Chem. 43:2000;3688.
20. Jayaraman M., Fox B.M., Hollingshead M., Kohlhagen G., Pommier Y., Cushman M. J. Med. Chem. 45:2000;242.
21. Spicer J.A., Gamage S.A., Rewcastle G.W., Funlay G.J., Bridewell D.J., Baguley B.C., Denny W.A. J. Med. Chem. 43:2000;1350.
22. Vicker N., Burgess L., Chuckowree I.S., Dodd R., Folkes A.J., Hardick D., Hancox T.C., Miller W., Milton J., Sohal S., Wang S., Wren S.P., Charlton P.A., Dangerfield W., Liddle C., Mistry P., Stewart A.J., Denny W.A. J. Med. Chem. 45:2002;721.
23. Gatto B., Sanders M.M., Yu C., Wu H-Y., Makhey D., LaVoie E.J., Liu L.F. Cancer Res. 56:1996;2795.
24. Wang L.-K., Rogers B.D., Hecht S.M. Chem. Res. Toxicol. 9:1996;75.
25. Wang L.K., Johnson R.K., Hecht S. Chem. Res. Toxicol. 6:1993;813.
26. Arisawa M., Pezzuto J.M., Bevelle C., Cordell G.A. J. Nat. Prod. 47:1984;453.
27. Pezzuto J.M., Antosiak J.K., Messmer W.M., Slaytor M.B., Honig G.R. Chem. Biol. Interact. 1983;323.
28. Wall M.E., Wani M.C., Tayleo E.C. J. Nat. Prod. 50:1987;1095.
29. Janin Y.L., Croisy A., Riou J-F., Bisagni E. J. Med. Chem. 36:1993;3686.
30. Zee-Cheng K.-Y., Paull K.D., Cheng C.C. J. Med. Chem. 17:1974;347.
31. Zee-Cheng R.K.Y., Cheng C.C. J. Med. Chem. 19:1976;882.
32. Makhey D., Yu C., Liu A., Liu L.F., LaVoie E.J. Bioorg. Med. Chem. 8:2000;1171.
33. Pettit G.R., Piatak D.M. J. Org. Chem. 25:1960;721.
34. Li D., Zhao B., LaVoie E.J. J. Org. Chem. 65:2000;2802.
35. Oikawa Y., Yonemitsu O. Tetrahedron. 30:1974;2653.
36. Aoyama T., Shioiri T. Tetrahedron Lett. 21:1980;4461.
37. McKervey M.A., Tuladhar S.M., Twohig M.F. J. Chem. Soc. Chem. Commun. 1984;129.
38. Sanders M.M., Liu A., Li T-K., Desai S., LaVoie E.J., Makhey D., Liu L.F. Biochem. Pharmacol. 56:1998;1157.
39. Ulrichova J., Walterova D., Simanek V. Acta. Univ. Palacki. Olomuc. 106:1984;31.
40. Gakunju D.M.N., Mberu E.K., Dossaji S.F., Gray A.I., Waigh R.D., Waterman P.G., Watkins W.M. Antimicrob. Agents Chemother. 39:1995;2606.
41. Hamlin, R.L.; Pipers, F.S.; Nguyen, K.; Milhalko, P.; Folk, R.M. U.S. NTIS, PB-261267, 72 pp From: Gov. Rep. Announce. Index (U.S.) 1977, 77, 94; Chem. Abstr. 1976, 87, 145670.
42. Caolo M.A., Stermitz F.R. Heterocycles. 12:1979;11.
43. Nichols D.E., Brewster W.K., Johnson M.P., Oberlender R., Rigs R.M. J. Med. Chem. 33:1990;703.
44. Halligan B.D., Edwards K.A., Liu L.F. J. Biol. Chem. 260:1985;2475.
45. Maniatis, T.; Fritsch, E. F.; Sambrook, J. In Molecular Cloning, a Laboratory Manual; Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1982; pp 149-185.
46. Liu L.F., Rowe T.C., Yang L., Tewey K.M., Chen G.L. J. Biol. Chem. 258:1983;15365.
47. Chen A.Y., Yu C., Bodley A.L., Peng L.F., Liu L.F. Cancer Res. 53:1993;1332.
48. Mosmann T.J. J. Immunol. Meth. 65:1983;55.
49. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Cancer Res. 47:1987;936.
50. Denizot F., Lang R. J. Immunol. Methods. 89:1986;271.
51. Andoh T., Okada K. Adv. Pharmacol. 29B:1994;93.